Opdivo vs Ibrance
Side-by-side drug price comparison from Medicare Part D data
Verdict
Ibrance costs 32% less per claim than Opdivo ($10816.00 vs $15821.00). Opdivo has a generic alternative available. Total Medicare spending: Opdivo at $5.1B vs Ibrance at $4.5B.
| Metric | Opdivo | Ibrance |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $15,821 | $10,816* |
| Total Medicare Spending Total Medicare Part D spending on this drug | $5.1B | $4.5B |
| Total Claims | 324,000 | 418,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 15.8% | -5.6%* |
| Generic Available | Yes | Yes |
| Condition | Cancer | Cancer |
| Total Beneficiaries | 66,000 | 36,000 |
Ibrance costs 32% less per claim than Opdivo ($10816.00 vs $15821.00). Opdivo has a generic alternative available. Total Medicare spending: Opdivo at $5.1B vs Ibrance at $4.5B.